Clinics and Research in Hepatology and Gastroenterology

Papers
(The H4-Index of Clinics and Research in Hepatology and Gastroenterology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Therapeutic benefit of probiotic in alcohol dependence syndrome: Evidence from a tertiary care centre of India43
Acute liver failure: Beyond the guidelines, the challenge of liver support therapies43
ARHGEF39 targeted by E2F1 fosters hepatocellular carcinoma metastasis by mediating fatty acid metabolism40
Editorial board39
Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease34
Contents31
An unusual endoscopic appearance of mantle cell lymphoma31
Pathological complete response of liver metastases of cholangiocarcinoma using hepatic intra-arterial gemcitabine-oxaliplatin31
Residential proximity to pesticide-treated farmland is associated with elevated liver enzymes29
The synergistic therapeutic effect of imatinib and protein kinase CK2 Inhibition correlates with PI3K-AKT activation in gastrointestinal stromal tumors25
Suicide risk is elevated among patients with chronic liver disease and cirrhosis in the United States25
Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis24
Generalizability and confounding in chemotherapy-induced hepatotoxicity: A call for robust risk stratification23
Hemorrhagic jejunal vascular malformations with loop telangiectasia in Turner’s syndrome23
Incidence and risk factors for rebleeding after emergency endoscopic hemostasis for marginal ulcer bleeding22
Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis22
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population20
Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis20
Hepatitis B virus-associated hepatocellular carcinoma with invasion into right atrium19
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients19
Neonatal jaundice caused by compound mutations of SLC10A1 and a novel UGT1A1 gene19
Gastric xanthelasma: A rare cause of gastrointestinal bleeding19
0.16326808929443